Viewing StudyNCT00088179



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00088179
Status: COMPLETED
Last Update Posted: 2018-02-22
First Post: 2004-07-21

Brief Title: Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass PRIMO-CABG II
Sponsor: Alexion Pharmaceuticals Inc
Organization: Alexion Pharmaceuticals Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-07
Start Date Type: ACTUAL
Primary Completion Date: 2005-10
Primary Completion Date Type: ACTUAL
Completion Date: 2005-10
Completion Date Type: ACTUAL
First Submit Date: 2004-07-21
First Submit QC Date: July 22 2004
Study First Post Date: 2004-07-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2017-02-15
Disp First Submit QC Date: February 15 2017
Disp First Post Date: 2017-02-16
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2018-02-20
Last Update Post Date: 2018-02-22
Last Update Post Date Type: ACTUAL